Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
135M
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
140M
-
Shares change
-
+12.7M
-
Total reported value, excl. options
-
$1.18B
-
Value change
-
+$109M
-
Put/Call ratio
-
0.1
-
Number of buys
-
83
-
Number of sells
-
-45
-
Price
-
$8.40
Significant Holders of Tango Therapeutics, Inc. - Common Stock (TNGX) as of Q3 2025
156 filings reported holding TNGX - Tango Therapeutics, Inc. - Common Stock as of Q3 2025.
Tango Therapeutics, Inc. - Common Stock (TNGX) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140M shares
.
Largest 10 shareholders include TRV GP IV, LLC (13.9M shares), FARALLON CAPITAL MANAGEMENT LLC (10.8M shares), EcoR1 Capital, LLC (10.6M shares), Boxer Capital Management, LLC (9.77M shares), TCG Crossover Management, LLC (8.54M shares), Woodline Partners LP (6.03M shares), Siren, L.L.C. (5.88M shares), BlackRock, Inc. (5.65M shares), Nextech Invest, Ltd. (5.53M shares), and VANGUARD GROUP INC (5.05M shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.